<DOC>
	<DOC>NCT02089061</DOC>
	<brief_summary>This purpose of this study is to assess the effects of BMS-919373 on the single dose Pharmacokinetics (PK) of Rosuvastatin and Atorvastatin in healthy subjects.</brief_summary>
	<brief_title>Drug Interaction Statin</brief_title>
	<detailed_description>Primary Purpose: Other - To assess the effects of BMS-919373 on the single dose PK of Rosuvastatin and Atorvastatin in healthy subjects</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com. Signed Written Informed Consent form Healthy subjects as determined by no clinically significant deviation from normal in medical and surgical history, physical examination, physical measurements, vital signs, 12lead ECG, 24hour telemetry, and clinical laboratory tests Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive Men and women, ages 18 to 55 yrs, inclusive Current or history of cardiovascular diseases, including arrhythmias, coronary heart disease, and congestive heart failure Current or history of symptomatic hypotension Current or history of liver diseases, including cirrhosis and liver failure Current or history of kidney diseases, including nephrotic syndrome, renal failure, nephrolithiasis, and urolithiasis Current or history of neurological diseases, including presyncope, syncope, convulsive disorders such as epilepsy, cerebral thrombosis and cerebral embolism, transient ischemic attack, and stroke; or mental disorders Exceptions for presyncope/syncope related to vasovagal responses are allowable at the discretion of the investigator History of significant head injury in the last 2 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>